IDEAYA Biosciences (IDYA) Current Leases (2019 - 2026)

IDEAYA Biosciences has reported Current Leases for 8 years, with the latest figure at $350000.0 in Q1 2026.

• Quarterly Current Leases rose 13.64% year-over-year to $350000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $350000.0 (up 13.64% YoY) and the FY2025 annual result came in at $339000.0, up 13.76% from the prior year.
• Current Leases advanced to $350000.0 in Q1 2026 per IDYA's latest filing, from $339000.0 in the prior quarter.
• Over five years, Current Leases peaked at $2.1 million in Q3 2023 and troughed at $298000.0 in Q4 2024.
• A 5-year average of $1.2 million and a median of $1.4 million in 2022 frame the typical range for Current Leases.
• The sharpest annual moves came in 2023 and 2024: Current Leases gained 14.78% in 2023, then slumped 82.94% in 2024.
• Over 5 years, Current Leases stood at $1.9 million in 2022, then dropped by 6.63% to $1.7 million in 2023, then plunged by 82.94% to $298000.0 in 2024, then climbed by 13.76% to $339000.0 in 2025, then advanced by 3.24% to $350000.0 in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $350000.0, $339000.0, and $328000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.